• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺血性心脏病和心力衰竭:冠状动脉离子通道的作用。

Ischemic Heart Disease and Heart Failure: Role of Coronary Ion Channels.

机构信息

Department of Clinical, Internal, Anesthesiology and Cardiovascular Sciences, Sapienza University of Rome, Viale del Policlinico, 155-00161 Rome, Italy.

出版信息

Int J Mol Sci. 2020 Apr 30;21(9):3167. doi: 10.3390/ijms21093167.

DOI:10.3390/ijms21093167
PMID:32365863
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7246492/
Abstract

Heart failure is a complex syndrome responsible for high rates of death and hospitalization. Ischemic heart disease is one of the most frequent causes of heart failure and it is normally attributed to coronary artery disease, defined by the presence of one or more obstructive plaques, which determine a reduced coronary blood flow, causing myocardial ischemia and consequent heart failure. However, coronary obstruction is only an element of a complex pathophysiological process that leads to myocardial ischemia. In the literature, attention paid to the role of microcirculation, in the pathophysiology of ischemic heart disease and heart failure, is growing. Coronary microvascular dysfunction determines an inability of coronary circulation to satisfy myocardial metabolic demands, due to the imbalance of coronary blood flow regulatory mechanisms, including ion channels, leading to the development of hypoxia, fibrosis and tissue death, which may determine a loss of myocardial function, even beyond the presence of atherosclerotic epicardial plaques. For this reason, ion channels may represent the link among coronary microvascular dysfunction, ischemic heart disease and consequent heart failure.

摘要

心力衰竭是一种导致高死亡率和高住院率的复杂综合征。缺血性心脏病是心力衰竭最常见的原因之一,通常归因于冠状动脉疾病,其特征是存在一个或多个阻塞性斑块,这会导致冠状动脉血流减少,引起心肌缺血和随后的心力衰竭。然而,冠状动脉阻塞只是导致心肌缺血的复杂病理生理过程的一个因素。在文献中,人们越来越关注微循环在缺血性心脏病和心力衰竭病理生理学中的作用。冠状动脉微血管功能障碍导致冠状动脉循环无法满足心肌代谢需求,这是由于包括离子通道在内的冠状动脉血流调节机制失衡所致,导致缺氧、纤维化和组织死亡,这可能导致心肌功能丧失,即使在存在动脉粥样硬化心外膜斑块的情况下也是如此。因此,离子通道可能是冠状动脉微血管功能障碍、缺血性心脏病和随后的心力衰竭之间的联系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a2/7246492/7a61aa2f98e9/ijms-21-03167-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a2/7246492/7a61aa2f98e9/ijms-21-03167-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a2/7246492/7a61aa2f98e9/ijms-21-03167-g001.jpg

相似文献

1
Ischemic Heart Disease and Heart Failure: Role of Coronary Ion Channels.缺血性心脏病和心力衰竭:冠状动脉离子通道的作用。
Int J Mol Sci. 2020 Apr 30;21(9):3167. doi: 10.3390/ijms21093167.
2
Myocardial Ischemia and Diabetes Mellitus: Role of Oxidative Stress in the Connection between Cardiac Metabolism and Coronary Blood Flow.心肌缺血与糖尿病:氧化应激在心脏代谢与冠脉血流连接中的作用。
J Diabetes Res. 2019 Apr 4;2019:9489826. doi: 10.1155/2019/9489826. eCollection 2019.
3
Diabetes Mellitus and Ischemic Heart Disease: The Role of Ion Channels.糖尿病与缺血性心脏病:离子通道的作用。
Int J Mol Sci. 2018 Mar 10;19(3):802. doi: 10.3390/ijms19030802.
4
Regulation of coronary blood flow in health and ischemic heart disease.健康与缺血性心脏病状态下的冠状动脉血流调节
Prog Cardiovasc Dis. 2015 Mar-Apr;57(5):409-22. doi: 10.1016/j.pcad.2014.12.002. Epub 2014 Dec 2.
5
Ischemic Heart Disease Pathophysiology Paradigms Overview: From Plaque Activation to Microvascular Dysfunction.缺血性心脏病病理生理学范式概述:从斑块激活到微血管功能障碍。
Int J Mol Sci. 2020 Oct 30;21(21):8118. doi: 10.3390/ijms21218118.
6
Microvascular dysfunction, myocardial ischemia, and progression to heart failure in patients with hypertrophic cardiomyopathy.肥厚型心肌病患者的微血管功能障碍、心肌缺血和心力衰竭进展。
J Cardiovasc Transl Res. 2009 Dec;2(4):452-61. doi: 10.1007/s12265-009-9142-5. Epub 2009 Nov 3.
7
Reappraisal of Ischemic Heart Disease.缺血性心脏病再评估。
Circulation. 2018 Oct 2;138(14):1463-1480. doi: 10.1161/CIRCULATIONAHA.118.031373.
8
Role of genetic polymorphisms of ion channels in the pathophysiology of coronary microvascular dysfunction and ischemic heart disease.离子通道遗传多态性在冠状动脉微血管功能障碍和缺血性心脏病病理生理学中的作用。
Basic Res Cardiol. 2013 Nov;108(6):387. doi: 10.1007/s00395-013-0387-4. Epub 2013 Sep 26.
9
Pathophysiology of coronary microvascular dysfunction.冠状动脉微血管功能障碍的病理生理学
Vascul Pharmacol. 2023 Dec;153:107239. doi: 10.1016/j.vph.2023.107239. Epub 2023 Oct 28.
10
Myocardial ischemia and coronary disease in heart failure.心力衰竭中的心肌缺血和冠状动脉疾病。
Heart Fail Rev. 2020 Jan;25(1):53-65. doi: 10.1007/s10741-019-09831-z.

引用本文的文献

1
MitoQ Protects Against Oxidative Stress-Induced Mitochondrial Dysregulation in Human Cardiomyocytes.MitoQ可保护人类心肌细胞免受氧化应激诱导的线粒体功能失调的影响。
J Mol Cell Cardiol Plus. 2025 Jun 26;13:100469. doi: 10.1016/j.jmccpl.2025.100469. eCollection 2025 Sep.
2
Mechanical and Hemocompatibility Assessment of Selected Technologies for Prosthesis Connection with the Outflow Cannula Graft of the RH PED Pediatric Pulsatile Pump for Heart Support.用于与RH PED小儿心脏支持搏动泵流出插管移植物进行假体连接的选定技术的机械和血液相容性评估。
J Clin Med. 2025 Jun 30;14(13):4621. doi: 10.3390/jcm14134621.
3
Enhanced Recovery and Reduced Complications with Minimally Invasive Coronary Artery Bypass Grafting Compared to Open Sternotomy.

本文引用的文献

1
Susceptibility to ischaemic heart disease: Focusing on genetic variants for ATP-sensitive potassium channel beyond traditional risk factors.缺血性心脏病易感性:聚焦于传统危险因素之外的ATP敏感性钾通道基因变异
Eur J Prev Cardiol. 2021 Oct 25;28(13):1495-1500. doi: 10.1177/2047487320926780.
2
Treatment of coronary microvascular dysfunction.冠状动脉微血管功能障碍的治疗。
Cardiovasc Res. 2020 Mar 1;116(4):856-870. doi: 10.1093/cvr/cvaa006.
3
ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on 'coronary microvascular dysfunction in cardiovascular disease'.
与开胸手术相比,微创冠状动脉旁路移植术可提高恢复效果并减少并发症。
Acta Inform Med. 2025;33(2):135-139. doi: 10.5455/aim.2025.33.135-139.
4
Aptamer-Based Planar Electric Double-Layer Field-Effect Transistor: A Novel Approach for Sensitive Troponin I Sensing.基于适配体的平面双电层场效应晶体管:一种用于灵敏检测肌钙蛋白I的新方法。
Biosensors (Basel). 2025 Apr 30;15(5):285. doi: 10.3390/bios15050285.
5
Simultaneous F-labeled AlF-FAPI PET/MR images targeting the myocardial fibrosis in coronary artery disease and degenerative mitral valve regurgitant participants with left ventricular mechanical dyssynchrony.针对患有左心室机械不同步的冠状动脉疾病和退行性二尖瓣反流参与者的心肌纤维化的同时F标记的AlF-FAPI PET/MR图像。
Clinics (Sao Paulo). 2025 Mar 25;80:100624. doi: 10.1016/j.clinsp.2025.100624. eCollection 2025.
6
Diet and the gut microbiota profiles in individuals at risk of chronic heart failure - A review on the Asian population.慢性心力衰竭高危个体的饮食与肠道微生物群特征——关于亚洲人群的综述
Asia Pac J Clin Nutr. 2025 Apr;34(2):141-152. doi: 10.6133/apjcn.202504_34(2).0001.
7
Heart failure and microvascular dysfunction: an in-depth review of mechanisms, diagnostic strategies, and innovative therapies.心力衰竭与微血管功能障碍:机制、诊断策略及创新疗法的深入综述
Ann Med Surg (Lond). 2024 Dec 24;87(2):616-626. doi: 10.1097/MS9.0000000000002971. eCollection 2025 Feb.
8
A Review of Contributing Factors to Heart Failure: Genetic, Lifestyle, and Environmental Influences.心力衰竭的促成因素综述:遗传、生活方式及环境影响
J Pharm Bioallied Sci. 2024 Dec;16(Suppl 5):S4299-S4305. doi: 10.4103/jpbs.jpbs_1328_24. Epub 2025 Jan 30.
9
Chronic Heart Failure and Coronary Artery Disease: Pharmacological Treatment and Cardiac Rehabilitation.慢性心力衰竭与冠状动脉疾病:药物治疗与心脏康复
Medicina (Kaunas). 2025 Jan 24;61(2):211. doi: 10.3390/medicina61020211.
10
Somatic Genomic and Transcriptomic Changes in Single Ischemic Human Heart Cardiomyocytes.单个人类缺血性心肌细胞的体细胞基因组和转录组变化
Res Sq. 2025 Jan 31:rs.3.rs-5875531. doi: 10.21203/rs.3.rs-5875531/v1.
ESC 工作组关于“心血管疾病中的冠状动脉微血管功能障碍”的冠状动脉病理生理学和微循环立场文件
Cardiovasc Res. 2020 Mar 1;116(4):741-755. doi: 10.1093/cvr/cvaa003.
4
Coronary microvascular dysfunction in hypertrophy and heart failure.肥厚型心肌病和心力衰竭中的冠状动脉微血管功能障碍。
Cardiovasc Res. 2020 Mar 1;116(4):806-816. doi: 10.1093/cvr/cvaa023.
5
TRPC Channels: Dysregulation and Ca Mishandling in Ischemic Heart Disease.TRPC 通道:缺血性心脏病中的失调和钙处理异常。
Cells. 2020 Jan 10;9(1):173. doi: 10.3390/cells9010173.
6
Nicorandil: A drug with ongoing benefits and different mechanisms in various diseased conditions.尼可地尔:一种在各种疾病状态下具有持续获益和不同作用机制的药物。
Indian J Pharmacol. 2019 Sep-Oct;51(5):296-301. doi: 10.4103/ijp.IJP_298_19. Epub 2019 Nov 26.
7
Role of endothelial dysfunction in heart failure.内皮功能障碍在心力衰竭中的作用。
Heart Fail Rev. 2020 Jan;25(1):21-30. doi: 10.1007/s10741-019-09881-3.
8
Advanced Heart Failure and End-Stage Heart Failure: Does a Difference Exist.晚期心力衰竭与终末期心力衰竭:二者是否存在差异?
Diagnostics (Basel). 2019 Nov 1;9(4):170. doi: 10.3390/diagnostics9040170.
9
Electrocardiographic features, mapping and ablation of idiopathic outflow tract ventricular arrhythmias.特发性流出道室性心律失常的心电图特征、标测和消融。
J Interv Card Electrophysiol. 2020 Mar;57(2):207-218. doi: 10.1007/s10840-019-00617-9. Epub 2019 Oct 24.
10
AGEs impair Kv channel-mediated vasodilation of coronary arteries by activating the NF-κB signaling pathway in ZDF rats.AGEs 通过激活 ZDF 大鼠 NF-κB 信号通路损害钾通道介导的冠状动脉血管舒张。
Biomed Pharmacother. 2019 Dec;120:109527. doi: 10.1016/j.biopha.2019.109527. Epub 2019 Oct 17.